| Weight | 579.986 g/mol |
|---|---|
| Formula | C27H30ClNO11 |
| Hydrogen Acceptors | 12 |
| Hydrogen Donors | 6 |
| Aromatic Rings | 2 |
| Rotatable Bonds | 5 |
Epirubicin hydrochloride (56390-09-1)
Epirubicin · Ellence · Pharmorubicin
Score:
#1872 in Physics
,
#2292 in Biochemistry
,
#4591 in Biology
,
#5820 in Chemistry
"What do you need help with?"
LabBot
- Sigma-Aldrich - Search for Epirubicin hydrochloride
- Fisher Scientific - Search for Epirubicin hydrochloride
- TCI - Search for Epirubicin hydrochloride
- Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2Positive Operable Breast Cancer (Journal of Clinical Oncology, 2005)
- Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. (Journal of Clinical Oncology, 1997)
- Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. (Journal of Clinical Oncology, 1998)
- Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial (Journal of Clinical Oncology, 2006)
- Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. (Journal of Clinical Oncology, 2002)
- Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen (Clinical Cancer Research, 2007)
-
Predict GHS Hazards for Any Chemical in silico.
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. - Epirubicin
- Ellence
- Pharmorubicin
- 4' Epi DXR
- NSC 256942
- Farmorubicine
- Farmorubicina
- 4' Epi Adriamycin
- 4'-Epi-Doxorubicin
- EPI cell
- NSC256942
- NSC-256942
- EPIcell
- 4' Epiadriamycin
- IMI 28
- 4' Epi Doxorubicin
- Farmorubicin
- 4'-Epidoxorubicin
- IMI28
- 4' Epidoxorubicin
- 4'-Epi-DXR
- Epilem
- EPI-cell
- 4'-Epi-Adriamycin
- 4'-Epiadriamycin
- IMI-28
-
SMILESCC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl
-
InChIKeyMWWSFMDVAYGXBV-UHFFFAOYSA-N
Suppliers
Most-cited Publications
Areas of Application
Safety
Alternate Names
External Links
Similar Compounds
ADM hydrochloride
(25316-40-9, 56390-09-1)
27 alternate names
3 suppliers
Epirubicin hydrochloride
(25316-40-9, 56390-09-1)
27 alternate names
3 suppliers
Epirubicin hydrochloride
(56390-09-1)
27 alternate names
3 suppliers
DAUNORUBICIN HCL
(23541-50-6)
27 alternate names
3 suppliers
DAUNORUBICIN HYDROCHLORIDE
(71214-33-0, 23541-50-6)
27 alternate names
3 suppliers
daunorubcin hydrochloride
(63950-07-2, 23541-50-6, 67463-64-3)
27 alternate names
3 suppliers
23541-50-6
(23541-50-6)
27 alternate names
3 suppliers
idarubicin hydrochloride
(57852-57-0)
27 alternate names
3 suppliers
neohesperidin dihydrochalcone
(20702-77-6)
27 alternate names
3 suppliers
quercitrin
(522-12-3)
27 alternate names
3 suppliers
naringin
(10236-47-2)
27 alternate names
3 suppliers
METHACYCLINE HYDROCHLORIDE
(3963-95-9)
27 alternate names
3 suppliers
RUBRATOXIN B
(21794-01-4)
27 alternate names
3 suppliers
RUBRATOXIN B
(21794-01-4)
27 alternate names
3 suppliers
RUBRATOXINB
(21794-01-4)
27 alternate names
3 suppliers
RALOXIFENE HYDROCHLORIDE
(82640-04-8)
27 alternate names
3 suppliers
OXYTETRACYCLINE HYDROCHLORIDE
(2058-46-0)
27 alternate names
3 suppliers
TETRACYCLINE HYDROCHLORIDE
(64-75-5)
27 alternate names
3 suppliers
Doxycycline hyclate
(24390-14-5, 10592-13-9)
27 alternate names
3 suppliers
CALOTROPIN
(1986-70-5)
27 alternate names
3 suppliers
RUBRATOXIN A
(22467-31-8)
27 alternate names
3 suppliers
Doxycycline hydrochloride
(24390-14-5, 10592-13-9)
27 alternate names
3 suppliers
Metacycline
(3963-95-9, 914-00-1)
27 alternate names
3 suppliers
oxytetracycline
(79-57-2, 7179-50-2, 2058-46-0)
27 alternate names
3 suppliers
ATOVAQUONE
(94015-53-9, 95233-18-4)
27 alternate names
3 suppliers
demeclocycline
(127-33-3)
27 alternate names
3 suppliers
Convallatoxin
(508-75-8)
27 alternate names
3 suppliers
Convallaotoxin
(5822-57-1)
27 alternate names
3 suppliers
7-Hydroxystaurosporine
(112953-11-4)
27 alternate names
3 suppliers
OCHRATOXIN A
(303-47-9)
27 alternate names
3 suppliers
303-47-9
(303-47-9)
27 alternate names
3 suppliers
doxycycline
(564-25-0)
27 alternate names
3 suppliers
tetracycline
(60-54-8, 64-75-5)
27 alternate names
3 suppliers
ZOLPIDEM TARTRATE
(99294-93-6)
27 alternate names
3 suppliers
MINOCYCLINE HYDROCHLORIDE
(13614-98-7)
27 alternate names
3 suppliers
DEMECLOCYCLINE HYDROCHLORIDE
(64-73-3, 127-33-3)
27 alternate names
3 suppliers
Orphenadrine citrate
(4682-36-4)
27 alternate names
3 suppliers
Physostigmine salicylate
(57-64-7)
27 alternate names
3 suppliers
Validamycin
(37248-47-8)
27 alternate names
3 suppliers
iopamidol
(60166-93-0)
27 alternate names
3 suppliers
SARAFLOXACIN HYDROCHLORIDE
(91296-87-6)
27 alternate names
3 suppliers
CARMINIC ACID
(1390-65-4, 1260-17-9)
27 alternate names
3 suppliers
Carmine
(1390-65-4, 1260-17-9, 1343-78-8)
27 alternate names
3 suppliers
CARMINIC ACID
(1390-65-4, 1260-17-9)
27 alternate names
3 suppliers
82508-31-4
(82508-31-4)
27 alternate names
3 suppliers
Carmine
(1390-65-4, 1260-17-9)
27 alternate names
3 suppliers
Ponceau xylidine
(7481-49-4, 3761-53-3)
27 alternate names
1 safety hazard
3 suppliers
7481-49-4
(7481-49-4, 3761-53-3)
27 alternate names
1 safety hazard
3 suppliers
RHODAMINE 6G
(989-38-8)
27 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
27 alternate names
3 suppliers
64-75-5
(64-75-5)
27 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
27 alternate names
3 suppliers
14930-96-2
(14930-96-2)
27 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
27 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
27 alternate names
3 suppliers
OCHRATOXIN C
(4865-85-4)
27 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
27 alternate names
3 suppliers
Noscapine hydrchloride
(912-60-7)
27 alternate names
3 suppliers
Depo-medrol
(53-36-1)
27 alternate names
3 suppliers
Diethylstilbestrol dipropionate
(37221-14-0, 130-80-3)
27 alternate names
3 suppliers
Phorbol 12,13-dibutyrate
(61557-88-8, 37558-16-0)
27 alternate names
3 suppliers
BAMBUTEROL HYDROCHLORIDE
(81732-46-9)
27 alternate names
3 suppliers
VERATRAMINE
(60-70-8)
27 alternate names
3 suppliers
Pibenzimol
(23491-44-3, 23491-45-4)
27 alternate names
3 suppliers
Methylprednisolone acetate
(53-36-1)
27 alternate names
3 suppliers
Disperse Red 60
(17418-58-5, 70956-30-8, 12223-37-9)
27 alternate names
3 suppliers
Methylprednisolone acetate
(53-36-1)
27 alternate names
3 suppliers
Xanthohumol
(6754-58-1)
27 alternate names
3 suppliers
CAS Directory
